National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

Bowman-Birk inhibitor concentrate
An extract of soybeans enriched in Bowman-Birk inhibitor (BBI), a soybean-derived, 71-amino acid, polypeptide and serine protease inhibitor with potential chemopreventive activity. Bowman-Birk inhibitor contains distinct inhibitory sites for trypsin and chymotrypsin. Although the exact mechanism by which BBI suppresses carcinogenesis is unknown, its antiproliferative activity appears to be linked to the chymotrypsin inhibitory region. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Abbreviation:BBIC



Previous:Boniva, boronophenylalanine-fructose complex, bortezomib, bosutinib, Boswellia serrata extract
Next:Brassica vegetable, brequinar, brivanib alaninate, broad-spectrum human papillomavirus vaccine V505, broccoli sprout extract

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov